作者
Paul England

Dr Paul England

高级专业支持律师

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More
作者
Paul England

Dr Paul England

高级专业支持律师

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

2019年4月18日

Answering one question and raising others – the CJEU on SPCs for new formulations

This month on Synapse

Answering one question and raising others - the CJEU on SPCs for new formulations

Anja Lunze explains the latest ruling of the CJEU on SPCs, concerning whether new formulations of an active ingredient can be protected.

Territorial Licensing

We explore the practice of geographical licensing, by which the owner of the rights to a product grants to a licensee the exclusive right to develop and/or commercialise the product in a specific country or territory only.

The UK Supreme Court rules on inventive step

Paul England explains the meaning of the ruling on inventive step in the UK Supreme Court decision Actavis v ICOS

Judicial review of marketing authorisation refused

Angus Milne reviews the decision by the UK Administrative Court to refuse a judicial review of the grant of a marketing authorisation for a generic medicinal product, DexEP.

Brexit update – 'Grandfathering' marketing authorisations

Paul England provides the latest update on the date of Brexit and guidance from the MHRA and PMCPA on 'grandfathering'.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

Synapse - January 2020

2020年1月16日

作者

点击此处了解更多
酒店与休闲

Synapse - December 2019

2019年12月19日

作者

点击此处了解更多
酒店与休闲

Synapse - November 2019

2019年11月26日

作者 Verena Bertram 以及 Dr Paul England

点击此处了解更多